Skip to content
Axcess News – Lifestyle
Author:
ACCRO BIOSCIENCE
Absci Reports Business Updates and Second Quarter 2026 Financial and Operating Results
August 12, 2026
Accro Bioscience Announces $50 Million Series C Financing Led by OrbiMed to Advance Clinical Pipeline for Immune Mediated Diseases
May 18, 2026